跳至主要内容
临床试验/NCT05573763
NCT05573763已完成不适用

Evaluation of the F&P Toffee Nasal Pillows Mask, US, 2022

Fisher and Paykel Healthcare2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2022年11月14日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
40
试验地点
2
主要终点
Epworth Sleepiness Scale

研究概览

简要总结

The purpose of this clinical investigation is to evaluate the performance and safety of the F&P Toffee nasal pillows mask in a home environment.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
22 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Persons who are ≥22 years of age
  • Persons who weigh ≥66 pounds
  • Persons who have been prescribed PAP therapy by a physician
  • Persons who are existing nasal pillows mask users with at ≥3 months of use prior to enrolment in the clinical trial
  • Persons who are compliant with PAP therapy for ≥4 hours per night for ≥70% of nights for a 14-day period within 30 days prior to enrolment in the clinical trial
  • Persons who are fluent in spoken and written English
  • Persons who possess the capacity to provide informed consent

排除标准

  • Persons who are intolerant to PAP therapy
  • Persons who possess, or suffer from, anatomical or physiological conditions which make PAP therapy inappropriate
  • Persons who are required to use PAP therapy for >12 hours per day or for extensive periods, not including sleep or naps
  • Persons who are trying to get pregnant, are pregnant, or think they may be pregnant
  • Persons who have an IPAP pressure of >25 cmH2O if on BPAP
  • Persons who use a PAP therapy device for the delivery of medicines, except supplemental O2
  • Persons who use a PAP therapy device that does not possess data recording capabilities to capture AHI and a numerical indicator of leak that is accessible to the investigation site

结局指标

主要结局

Epworth Sleepiness Scale

时间窗: 14±5 days

All relevant time points used in the calculation in the Time Frame (e.g., baseline and 14±5 days). Note: change was calculated from two time points as the value at the later time point minus the value at the earlier time point (e.g., value at 14±5 days minus value at baseline). Change between two time points is reported. Scale range: 0 (minimum score) to 24 (maximum score) (higher scores represent worse outcomes)

Therapeutic Efficacy

时间窗: Baseline and 14±5 days

Determined by Apnea-Hypopnea Index (AHI) recorded on PAP therapy machines after 14 days of use. The Apnea-Hypopnea index (AHI) is the sum of the apneas and hypopneas divided by the hours of sleep. AHI values are typically categorized as 5-15/hr = mild; 15-30/hr = moderate; and \>= 30/h = severe"

Epworth Sleepiness Scale

时间窗: 14±5 days

All relevant time points used in the calculation in the Time Frame (e.g., baseline and 14±5 days). Note: change was calculated from two time points as the value at the later time point minus the value at the earlier time point (e.g., value at 14±5 days minus value at baseline). Change between two time points is reported. Scale range: 0 (minimum score) to 24 (maximum score) (higher scores represent worse outcomes)

次要结局

未报告次要终点

研究者

发起方
Fisher and Paykel Healthcare
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Evaluation of the F&P Toffee Nasal Pillows Mask, US,... | 临床试验